Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

CUSIP: 702712100

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
3,182,163
Total 13F shares
1,232,073
Share change
-2,243,774
Total reported value
$1,538,826
Price per share
$1.42
Number of holders
8
Value change
-$4,445,404
Number of buys
2
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q3 2022

As of 30 Sep 2022, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,232,073 shares. The largest 8 holders included Erste Asset Management GmbH, Russell Investments Group, Ltd., BARCLAYS PLC, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, Global Trust Asset Management, LLC, China Universal Asset Management Co., Ltd., and US BANCORP \DE\. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.